These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 18430526)
1. Testing the efficacy of medium chain fatty acids against rabbit colibacillosis. Gallois M; Gidenne T; Orengo J; Caubet C; Tasca C; Milon A; Boullier S Vet Microbiol; 2008 Sep; 131(1-2):192-8. PubMed ID: 18430526 [TBL] [Abstract][Full Text] [Related]
2. Maternal milk contains antimicrobial factors that protect young rabbits from enteropathogenic Escherichia coli infection. Gallois M; Gidenne T; Tasca C; Caubet C; Coudert C; Milon A; Boullier S Clin Vaccine Immunol; 2007 May; 14(5):585-92. PubMed ID: 17344351 [TBL] [Abstract][Full Text] [Related]
3. The possible influence of LuxS in the in vivo virulence of rabbit enteropathogenic Escherichia coli. Zhu C; Feng S; Sperandio V; Yang Z; Thate TE; Kaper JB; Boedeker EC Vet Microbiol; 2007 Dec; 125(3-4):313-22. PubMed ID: 17643872 [TBL] [Abstract][Full Text] [Related]
4. Towards a vaccine for attaching/effacing Escherichia coli: a LEE encoded regulator (ler) mutant of rabbit enteropathogenic Escherichia coli is attenuated, immunogenic, and protects rabbits from lethal challenge with the wild-type virulent strain. Zhu C; Feng S; Thate TE; Kaper JB; Boedeker EC Vaccine; 2006 May; 24(18):3845-55. PubMed ID: 16112258 [TBL] [Abstract][Full Text] [Related]
5. A directed intimin insertion mutant of a rabbit enteropathogenic Escherichia coli (REPEC) is attenuated, immunogenic and elicits serogroup specific protection. Ahmed S; Byrd W; Kumar S; Boedeker EC Vet Immunol Immunopathol; 2013 Mar; 152(1-2):146-55. PubMed ID: 23084628 [TBL] [Abstract][Full Text] [Related]
6. Simultaneous inactivation of espB and tir abrogates the strong, but non-protective, inflammatory response induced by EPEC. Lefoll C; Caubet C; Tasca C; Milon A; Boullier S Vet Immunol Immunopathol; 2010 Nov; 138(1-2):34-44. PubMed ID: 20633933 [TBL] [Abstract][Full Text] [Related]
7. Effects of caprylic acid and triacylglycerols of both caprylic and capric acid in rabbits experimentally infected with enteropathogenic Escherichia coli O103. Skrivanová E; Molatová Z; Marounek M Vet Microbiol; 2008 Jan; 126(4):372-6. PubMed ID: 17703901 [TBL] [Abstract][Full Text] [Related]
8. Genetically engineered enteropathogenic Escherichia coli strain elicits a specific immune response and protects against a virulent challenge. Boullier S; Nougayrède JP; Marchès O; Tasca C; Boury M; Oswald E; De Rycke J; Milon A Microbes Infect; 2003 Aug; 5(10):857-67. PubMed ID: 12919854 [TBL] [Abstract][Full Text] [Related]
9. Inhibitory activity of rabbit milk and medium-chain fatty acids against enteropathogenic Escherichia coli O128. Skrivanová E; Molatová Z; Skrivanová V; Marounek M Vet Microbiol; 2009 Mar; 135(3-4):358-62. PubMed ID: 19019572 [TBL] [Abstract][Full Text] [Related]
10. New flow cytometric method to quantify the inhibition of enteropathogenic Escherichia coli adhesion by anti-adhesin antibodies. Boullier S; Tasca C; Milon A Cytometry A; 2003 Jun; 53(2):79-87. PubMed ID: 12766969 [TBL] [Abstract][Full Text] [Related]
11. Oral infection with enteropathogenic Escherichia coli triggers immune response and intestinal histological alterations in mice selected for their minimal acute inflammatory responses. Vulcano AB; Tino-De-Franco M; Amaral JA; Ribeiro OG; Cabrera WH; Bordenalli MA; Carbonare CB; Álvares EP; Carbonare SB Microbiol Immunol; 2014 Jun; 58(6):352-9. PubMed ID: 24750489 [TBL] [Abstract][Full Text] [Related]
12. Genetic characterization of antibiotic resistance in enteropathogenic Escherichia coli carrying extended-spectrum beta-lactamases recovered from diarrhoeic rabbits. Poeta P; Radhouani H; Gonçalves A; Figueiredo N; Carvalho C; Rodrigues J; Igrejas G Zoonoses Public Health; 2010 May; 57(3):162-70. PubMed ID: 19309480 [TBL] [Abstract][Full Text] [Related]
13. Human milk oligosaccharides protect against enteropathogenic Escherichia coli attachment in vitro and EPEC colonization in suckling mice. Manthey CF; Autran CA; Eckmann L; Bode L J Pediatr Gastroenterol Nutr; 2014 Feb; 58(2):165-8. PubMed ID: 24048169 [TBL] [Abstract][Full Text] [Related]
14. Diarrheagenic Escherichia coli pathotypes investigation revealed atypical enteropathogenic E. coli as putative emerging diarrheal agents in children living in Botucatu, São Paulo State, Brazil. Dias RC; Dos Santos BC; Dos Santos LF; Vieira MA; Yamatogi RS; Mondelli AL; Sadatsune T; Sforcin JM; Gomes TA; Hernandes RT APMIS; 2016 Apr; 124(4):299-308. PubMed ID: 26752102 [TBL] [Abstract][Full Text] [Related]
15. Rabbit EPEC: a model for the study of enteropathogenic Escherichia coli. Milon A; Oswald E; De Rycke J Vet Res; 1999; 30(2-3):203-19. PubMed ID: 10367355 [TBL] [Abstract][Full Text] [Related]
16. Decreased apoptosis in the ileum and ileal Peyer's patches: a feature after infection with rabbit enteropathogenic Escherichia coli O103. Heczko U; Carthy CM; O'Brien BA; Finlay BB Infect Immun; 2001 Jul; 69(7):4580-9. PubMed ID: 11402002 [TBL] [Abstract][Full Text] [Related]
17. Protection of rabbits against enteropathogenic Escherichia coli (EPEC) using an intimin null mutant. Stakenborg T; Vandekerchove D; Mariën J; Laevens H; Imberechts H; Peeters J BMC Vet Res; 2006 Jun; 2():22. PubMed ID: 16796739 [TBL] [Abstract][Full Text] [Related]
18. LEE-encoded regulator (Ler) mutants elicit serotype-specific protection, but not cross protection, against attaching and effacing E. coli strains. Zhu C; Feng S; Yang Z; Davis K; Rios H; Kaper JB; Boedeker EC Vaccine; 2007 Feb; 25(10):1884-92. PubMed ID: 17234305 [TBL] [Abstract][Full Text] [Related]
19. Oral vaccination of weaned rabbits against enteropathogenic Escherichia coli-like E. coli O103 infection: use of heterologous strains harboring lipopolysaccharide or adhesin of pathogenic strains. Milon A; Esslinger J; Camguilhem R Infect Immun; 1992 Jul; 60(7):2702-9. PubMed ID: 1351880 [TBL] [Abstract][Full Text] [Related]
20. Mice vaccinated with enteropathogenic Escherichia coli ghosts show significant protection against lethal challenges. Liu J; Wang WD; Liu YJ; Liu S; Zhou B; Zhu LW; Ji X; Sun Y; Feng SZ Lett Appl Microbiol; 2012 Mar; 54(3):255-62. PubMed ID: 22211792 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]